本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

157.54
+0.34000.22%
盘后157.540.00000.00%19:56 EDT
成交量:34.26万
成交额:5,341.48万
市值:95.11亿
市盈率:-25.03
高:159.03
开:157.14
低:150.89
收:157.20
数据加载中...
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]